'김갑성' 기자의 전체기사
-
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company…
[ 메디채널 김갑성 기자 ] WuXi AppTec sets new benchmarks in strategic execution and technological advancement, further strengthening its ability to support innovators worldwide as they deliver breakthrough medicines for patients. SAN ANTONIO, Nov. 20, 2025 -- Frost & Sullivan is pleased to announce that WuXi AppTec has received the 2025 Global Company of the Year Recognition in the contract research, development, and manufacturing organization (CRDMO) industry for its outstanding achievements in enabling innovation, operational excellence, and customer impact. This recognition underscores
- 김갑성 기자
- 2025-11-20 10:00
-
Dr James Liang Launches HK$500 Million "Genovation Found…
HONG KONG, Nov. 20, 2025 -- On World Children's Day, Dr James Liang, Co-founder of Trip.com Group, announced the establishment of the Genovation Foundation Limited in Hong Kong. Established in his personal capacity, the foundation pledges HK$500 million over five years to address declining fertility through three key avenues: economic subsidies, cultural advocacy, and policy research. The name Genovation combines "Gene" and "Innovation", symbolising both the continuity of life and the pursuit of creative solutions to pressing social challenges. This marks another si
- 김갑성 기자
- 2025-11-20 10:00
-
USANA Named No. 1 Dietary Supplements Brand in the Philippine…
Euromonitor Recognizes USANA Philippines as the Market Leader from 2019 to 2025 MANILA, Philippines, Nov. 20, 2025 -- USANA Health Sciences, Inc., a global leader in health and wellness, has once again been recognized as the No. 1 dietary supplements brand in the Philippines* by Euromonitor International—marking an unprecedented seven consecutive years at the top (2019–2025). This continued recognition underscores USANA's unwavering commitment to delivering science-based nutrition, premium-quality products, and exceptional trust among Filipino consumers. &
- 김갑성 기자
- 2025-11-20 09:16
-
ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Makin…
MELBOURNE, Australia and INDIANAPOLIS, Nov. 20, 2025 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces results from the ZIRCON-X study which finds that almost half of all patients imaged with TLX250-CDx (Zircaix®[1], 89Zr-DFO-girentuximab) PET/CT[2] would have undergone a change in clinical management, when compared with baseline standard of care (SOC) imaging. The data will be presented at the 26th Annual Meeting of the Society of Urologic Oncology (SUO) being held in Phoenix, AZ, December 2 – 5, 2025. ZIRCON-X was a
- 김갑성 기자
- 2025-11-20 03:00
-
Dimora Medical Supports HS Connect Empower Workshop to Pr…
NEW YORK, Nov. 20, 2025 -- Patient-centered nonprofit organization HS Connect recently hosted the Empower HS: Knowledge and Advocacy Workshop, an educational event designed to help individuals living with Hidradenitis Suppurativa (HS) and their caregivers gain the knowledge and confidence to advocate for themselves. Dimora Medical, a continuous innovator in high-end medical care supplies, supported the event through product donations, joining in the effort to enhance public understanding, improve patient self-management, and advance scientific wound care practices. The workshop
- 김갑성 기자
- 2025-11-20 01:48
-
NABR: CITES Standing Committee Issues Assessment of Lon…
WASHINGTON, Nov. 20, 2025 -- The Standing Committee of CITES, an international body responsible for monitoring trade in animal species, announced the results of its review of animal breeding practices in Cambodia, thanking Cambodia for providing extensive data and relying on science. The report, released on Nov. 12, 2025 in advance of an upcoming Standing Committee meeting, is available at https://cites.org/eng/sc/79/agenda-documents. Among other positive findings, the report states that Cambodia has customs and inspection procedures in place that are "well-coordinated and
- 김갑성 기자
- 2025-11-20 01:33
-
BestQool Announces Up to 21% Off Red Light Therapy Devices…
NEW YORK, Nov. 19, 2025 -- This Black Friday, BestQool invites everyone to pause, breathe, and take a moment for themselves. Even a brief daily red light therapy session can help relax muscles, refresh the skin, and ease the day's tension. To make at-home wellness more accessible, BestQool is launching its official Black Friday promotion on Amazon. From 12:00 AM PST on November 20, 2025 to 11:59 PM PST on December 1, 2025, customers can enjoy: 20% off all BestQool products on Amazon, and an exclusive 21% discount on three of the brand's best-selling high-performance mode
- 김갑성 기자
- 2025-11-19 23:04
-
HKUST Commences Preparations for New Medical School
Inaugural Cohort in 2028, Cultivating Clinically Excellent and Technology-Savvy Doctors of the Future HONG KONG, Nov. 19, 2025 -- With the support of the HKSAR Government, The Hong Kong University of Science and Technology (HKUST) has commenced preparations to establish a new medical school. Dedicated to training a new generation of tech-savvy doctors, the School will bolster the future readiness of the local healthcare system and advance Hong Kong's development as an international hub for medical training, research, and innovation. Prof. Harry SHUM, HKUST Council Chairman, rema
- 김갑성 기자
- 2025-11-19 22:55
-
Accelerating Drug Discovery: Tsingke Biotech Unveils Next-G…
BEIJING and LISBON, Portugal, Nov. 19, 2025 -- At PEGS Europe 2025, one of the industry's premier gatherings for innovation in protein and antibody engineering, Tsingke Biotech highlighted its latest accelerated protein and antibody services. The leading Chinese biotechnology company announced that its services can generate proteins in as little as 3 days and produce antibodies within 7 days, offering a potential step-change in speed for biopharma developers aiming to shorten drug discovery timelines worldwide. High-Speed Protein Production Across Six Expression Systems
- 김갑성 기자
- 2025-11-19 22:17
-
Nona Biosciences and Pfizer Announce Strategic Researc…
Agreement includes license to Nona's fully human HCAb platform for preclinical antibody discovery CAMBRIDGE, Mass., Nov. 19, 2025 -- Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I® (Idea to IND), today announced a non-exclusive license agreement with Pfizer designed to accelerate preclinical antibody discovery across a range of potential disease indications. Under the terms of the agreement, Pfizer will gain global rights to access Nona's proprietary HCAb platform
- 김갑성 기자
- 2025-11-19 20:08
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 5하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 6대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 7만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2026-01-31_SAT
- JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL 20:58
- Sanyou Bio's Decade: From an Intelligent Super-Trillion Antibody Library to the "Innovation Hub for Original Drug Discovery" 16:15
- CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK 12:05
- Origin Agritech Announces Fiscal Year 2025 Results 06:00
- White Pearl Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering 05:47
- Planet Green Holdings Corp. Provides Response to Unusual Market Action 05:05
- SKF completes previously announced divestment of non-core aerospace operation in Elgin, USA 03:36
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2026년 01월 31일 22시 40분